↓ Skip to main content

A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome

Overview of attention for article published in Molecular Autism, December 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

news
1 news outlet
blogs
4 blogs
twitter
7 X users
patent
1 patent
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages
googleplus
1 Google+ user

Readers on

mendeley
152 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
Published in
Molecular Autism, December 2014
DOI 10.1186/2040-2392-5-54
Pubmed ID
Authors

Alexander Kolevzon, Lauren Bush, A Ting Wang, Danielle Halpern, Yitzchak Frank, David Grodberg, Robert Rapaport, Teresa Tavassoli, William Chaplin, Latha Soorya, Joseph D Buxbaum

Abstract

Autism spectrum disorder (ASD) is now understood to have multiple genetic risk genes and one example is SHANK3. SHANK3 deletions and mutations disrupt synaptic function and result in Phelan-McDermid syndrome (PMS), which causes a monogenic form of ASD with a frequency of at least 0.5% of ASD cases. Recent evidence from preclinical studies with mouse and human neuronal models of SHANK3 deficiency suggest that insulin-like growth factor-1 (IGF-1) can reverse synaptic plasticity and motor learning deficits. The objective of this study was to pilot IGF-1 treatment in children with PMS to evaluate safety, tolerability, and efficacy for core deficits of ASD, including social impairment and restricted and repetitive behaviors.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 3%
Spain 1 <1%
Germany 1 <1%
Unknown 146 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 16%
Student > Ph. D. Student 23 15%
Student > Master 22 14%
Student > Bachelor 14 9%
Other 8 5%
Other 27 18%
Unknown 33 22%
Readers by discipline Count As %
Medicine and Dentistry 26 17%
Neuroscience 21 14%
Agricultural and Biological Sciences 18 12%
Psychology 15 10%
Biochemistry, Genetics and Molecular Biology 11 7%
Other 23 15%
Unknown 38 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2024.
All research outputs
#953,084
of 25,654,806 outputs
Outputs from Molecular Autism
#80
of 722 outputs
Outputs of similar age
#11,858
of 364,723 outputs
Outputs of similar age from Molecular Autism
#4
of 11 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 722 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.8. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,723 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.